Non-alcoholic fatty liver disease, metabolic goal achievement with incident cardiovascular disease and eGFR-based chronic kidney disease in patients with prediabetes and diabetes
Mian Li, Zhiyun Zhao, Guijun Qin, Li Chen, Jieli Lu, Yanan Huo, Lulu Chen, Tianshu Zeng, Min Xu, Yuhong Chen, Tiange Wang, Shuangyuan Wang, Yiping Xu, Yiping Xu, Lixin Shi, Xulei Tang, Qing Su, Xuefeng Yu, Li Yan, Qin Wan, Gang Chen, Zhengnan Gao, Guixia Wang, Feixia Shen, Zuojie Luo, Yinfei Zhang, Chao Liu, Youmin Wang, Ruying Hu, Zhen Ye, Shengli Wu, Huacong Deng, Tao Yang, Qiang Li, Yingfen Qin, Yiming Mu, Jiajun Zhao, Guang Ning, Yufang Bi, Yu Xu, Yu Xu, Weiqing Wang
Topics & Concepts
MedicineInternal medicineHazard ratioKidney diseaseAspartate transaminasePrediabetesFatty liverProspective cohort studyAlanine transaminaseDiabetes mellitusCohortPopulationType 2 diabetesDiseaseConfidence intervalEndocrinologyEnvironmental healthChemistryEnzymeAlkaline phosphataseBiochemistryLiver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and LipoproteinsChronic Kidney Disease and Diabetes